Image6_Hypoxia-induced PD-L1 expression and modulation of muscle stem cell allograft rejection.JPEG

Image6_Hypoxia-induced PD-L1 expression and modulation of muscle stem cell allograft rejection.JPEG

<p>Stem cell therapy has shown immense promise in treating genetic disorders, particularly muscular diseases like Duchenne muscular dystrophy (DMD). This study investigates a novel method to enhance the viability of stem cell transplants in DMD by upregulating Programmed Death Ligand 1 (PD-L1)...

Full description

Saved in:
Bibliographic Details
Main Author: Jacob Raiten (20021262) (author)
Other Authors: Genevieve M. Abd (20021265) (author), Shane B. Handelsman (20021268) (author), Harshank V. Patel (20021271) (author), Jennifer C. Ku (20021274) (author), Agata M. Parsons (20021277) (author), Jonathan L. Wassink (20021280) (author), Sheridan L. Hayes (20021283) (author), Juliana Overbay (20021286) (author), Yong Li (15029) (author)
Published: 2024
Subjects:
Pharmacology
Basic Pharmacology
Clinical Pharmacology and Therapeutics
Clinical Pharmacy and Pharmacy Practice
Pharmaceutical Sciences
Pharmacogenomics
Toxicology (incl. Clinical Toxicology)
Pharmacology and Pharmaceutical Sciences not elsewhere classified
cell therapy
stem cell transplantation
duchenne muscular dystrophy (DMD)
Programmed death ligand 1
immune rejection
hypoxia preconditioning
muscle stem cells
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items